- To read more about “Glutaryl-CoA dehydrogenase deficiency”
- Genet Med . 2021 Jan;23(1):13-21.
(source: OrphaNews 10 May 2021)
Glutaryl-CoA dehydrogenase deficiency : a study showed that newborn screening programs for Glutaric aciduria type 1 have an overall positive effect on the neurological outcome but their success depends on the quality of therapy
Related news
Building a better future for rare diseases: campaigns launched at European and international level
EURORDIS and Rare Diseases International have launched, respectively, ...
The first International Neonatal Screening day is here!
It is more than 50 years since population newborn screening began. The...
Cystic fibrosis : a review of gene therapy for cystic fibrosis
Consult the pubmed abstract To read more about “Cystic fibrosis” M...
Phenylketonuria : a study showed study improvements in cognitive function, anxiety, and depression ratings associated with resumption of dietary control of phenylketonuria
Consult the pubmed abstract To read more about “Phenylketonuria” O...
European Alliance for Newborn Screening for Spinal Muscular Atrophy : New whitepaper on “Spinal muscular atrophy, screen at birth, save lives”
The European Alliance for Newborn Screening for Spinal Muscular Atroph...
Survey on patient organisations’ knowledge and position paper on screening for inherited neuromuscular diseases in Europe
A new study published in the Orphanet Journal of Rare Diseases aimed t...